These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20032294)

  • 1. Structural basis for the blockage of IL-2 signaling by therapeutic antibody basiliximab.
    Du J; Yang H; Zhang D; Wang J; Guo H; Peng B; Guo Y; Ding J
    J Immunol; 2010 Feb; 184(3):1361-8. PubMed ID: 20032294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of immunosuppression by the therapeutic antibody daclizumab.
    Yang H; Wang J; Du J; Zhong C; Zhang D; Guo H; Guo Y; Ding J
    Cell Res; 2010 Dec; 20(12):1361-71. PubMed ID: 20820193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab.
    Binder M; Vögtle FN; Michelfelder S; Müller F; Illerhaus G; Sundararajan S; Mertelsmann R; Trepel M
    Cancer Res; 2007 Apr; 67(8):3518-23. PubMed ID: 17440057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One target-two different binding modes: structural insights into gevokizumab and canakinumab interactions to interleukin-1β.
    Blech M; Peter D; Fischer P; Bauer MM; Hafner M; Zeeb M; Nar H
    J Mol Biol; 2013 Jan; 425(1):94-111. PubMed ID: 23041424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of basiliximab in solid organ transplantation.
    Henry ML; Rajab A
    Expert Opin Pharmacother; 2002 Nov; 3(11):1657-63. PubMed ID: 12437498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of basiliximab induction therapy in organ transplantation.
    Ramirez CB; Marino IR
    Expert Opin Biol Ther; 2007 Jan; 7(1):137-48. PubMed ID: 17150025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-18 receptor beta-induced changes in the presentation of IL-18 binding sites affect ligand binding and signal transduction.
    Wu C; Sakorafas P; Miller R; McCarthy D; Scesney S; Dixon R; Ghayur T
    J Immunol; 2003 Jun; 170(11):5571-7. PubMed ID: 12759435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monoclonal interleukin-2 receptor antibodies and their use in clinical kidney transplantation: basiliximab and daclizumab].
    Madsen M; Svendsen UG
    Ugeskr Laeger; 2000 Oct; 162(42):5648-52. PubMed ID: 11059309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
    Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a monoclonal antibody directed against the NH2 terminal area of interleukin-2 (IL-2) and inhibiting specifically the binding of IL-2 to IL-2 receptor beta chain (IL-2R beta).
    Moreau JL; Bossus M; de Groote D; François C; Jacques Y; Tartar A; Thèze J
    Mol Immunol; 1995 Oct; 32(14-15):1047-56. PubMed ID: 8544854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water channel in the binding site of a high affinity anti-methotrexate antibody.
    Gayda S; Longenecker KL; Manoj S; Judge RA; Saldana SC; Ruan Q; Swift KM; Tetin SY
    Biochemistry; 2014 Jun; 53(23):3719-26. PubMed ID: 24832237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1.
    Redpath NT; Xu Y; Wilson NJ; Fabri LJ; Baca M; Andrews AE; Braley H; Lu P; Ireland C; Ernst RE; Woods A; Forrest G; An Z; Zaller DM; Strohl WR; Luo CS; Czabotar PE; Garrett TP; Hilton DJ; Nash AD; Zhang JG; Nicola NA
    Biochem J; 2013 Apr; 451(2):165-75. PubMed ID: 23384096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the Fab fragment of the anti-murine EGFR antibody 7A7 and exploration of its receptor binding site.
    Talavera A; Mackenzie J; Garrido G; Friemann R; López-Requena A; Moreno E; Krengel U
    Mol Immunol; 2011 Jul; 48(12-13):1578-85. PubMed ID: 21592580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The murine anti-human common gamma chain monoclonal antibody CP.B8 blocks the second step in the formation of the intermediate affinity IL-2 receptor.
    Baker DP; Whitty A; Zafari MR; Olson DL; Hession CA; Miatkowski K; Avedissian LS; Foley SF; McKay ML; Benjamin CD; Burkly LC
    Biochemistry; 1998 Oct; 37(41):14337-49. PubMed ID: 9772159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human anti-human IL-18 antibody recognizing the IL-18-binding site 3 with IL-18 signaling blocking activity.
    Hamasaki T; Hashiguchi S; Ito Y; Kato Z; Nakanishi K; Nakashima T; Sugimura K
    J Biochem; 2005 Oct; 138(4):433-42. PubMed ID: 16272137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule inhibitors of IL-2/IL-2R: lessons learned and applied.
    Wilson CG; Arkin MR
    Curr Top Microbiol Immunol; 2011; 348():25-59. PubMed ID: 20703966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategy for acute rejection in organ transplantation--optimal use of monoclonal antibody].
    Hanafusa T; Takahara S
    Nihon Rinsho; 2002 Mar; 60(3):598-602. PubMed ID: 11904979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of NGF-TrkA receptor interaction by the novel antagonistic anti-TrkA monoclonal antibody MNAC13: a structural insight.
    Covaceuszach S; Cattaneo A; Lamba D
    Proteins; 2005 Feb; 58(3):717-27. PubMed ID: 15625712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different binding modes of free and carrier-protein-coupled nicotine in a human monoclonal antibody.
    Tars K; Kotelovica S; Lipowsky G; Bauer M; Beerli RR; Bachmann MF; Maurer P
    J Mol Biol; 2012 Jan; 415(1):118-27. PubMed ID: 22079050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of intragraft IL-2 receptor-alpha by basiliximab is insufficient to prevent activation of liver graft infiltrating cells.
    Kwekkeboom J; Warlé MC; Rietveld J; Segeren KC; Tilanus HW; Metselaar HJ
    Transpl Immunol; 2003; 11(1):1-5. PubMed ID: 12727469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.